Zacks.com on MSN6d
MRK Gets Positive CHMP Nod for 21-Valent Pneumococcal Jab Capvaxive
The Committee for Medicinal Products for Human Use recommends approval for Merck's pneumococcal 21-valent conjugate vaccine, ...
PMLiVE4d
Merck’s adult-specific pneumococcal vaccine Capvaxive recommended by CHMP
The Committee for Medicinal Products for Human Use (CHMP) has recommended that Capvaxive be used to prevent invasive disease ...
Yahoo Finance6d
MRK Gets Positive CHMP Nod for 21-Valent Pneumococcal Jab Capvaxive
Merck MRK announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of its 21-valent pneumococcal conjugate vaccine ...
Pharmabiz6d
Merck receives positive EU CHMP opinion for Capvaxive for pneumococcal vaccination in adults
Merck receives positive EU CHMP opinion for Capvaxive for pneumococcal vaccination in adults: Rahway, New Jersey Monday, February 3, 2025, 12:00 Hrs [IST] Merck, known as MSD outs ...
24/7 Wall St. on MSN1d
Wall Street Analysts Thought Merck Stock Had 10% Downside Risk Heading Into Earnings. That Materialized, So What's Next?
Merck & Co. (NYSE:MRK) is a prominent American multinational pharmaceutical company many investors know for its brand-name ...
24/7 Wall St2d
Wall Street Analysts Thought Merck Stock Had 10% Downside Risk Heading Into Earnings. That Materialized, So What's Next?
Merck secured a positive recommendation from the European Medicines Agency’s CHMP for its pneumococcal vaccine, CAPVAXIVE™, a key step toward EU approval. The European Commission’s decision ...